secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0000950170-25-003794
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics posts updated corporate presentation on website
--------------------------------------------------------------------

- Company filed an 8-K announcing an updated slide presentation posted on January 10, 2025.
- Presentation will be used in meetings with investors, analysts, and other parties.
- No specific new financial or clinical data disclosed in the filing or attached exhibit text.
- Exhibit 99.1 text was not provided; only a fragment referencing the deck title is available.
- Update appears routine with no material new information for investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025003794/0000950170-25-003794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025003794/lrmr-20250109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-003794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer